ADAM17 mRNA expression and pathological features of hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

232

HTML

2454

Figures (1-3)

110

Tables (1-2)

129

Sum=2925

Sep 15, 2004 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Sep 15, 2004; 10(18): 2735-2739
Published online Sep 15, 2004. doi: 10.3748/wjg.v10.i18.2735

Figure 1 ADAM17 transcription was detected in HCC but no obvious transcription was observed in paired non-cancerous tissues.

Figure 2 The expression of ADAM17 mRNA was higher in NHCC compared with SHCC and SLHCC.

Figure 3 Transcription level of ADAM17 in three groups of HCC.

Citation: Ding X, Yang LY, Huang GW, Wang W, Lu WQ. ADAM17 mRNA expression and pathological features of hepatocellular carcinoma. World J Gastroenterol 2004; 10(18): 2735-2739
URL: https://www.wjgnet.com/1007-9327/full/v10/i18/2735.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i18.2735